InvestorsHub Logo

flipper44

07/08/22 11:52 AM

#493476 RE: exwannabe #493474

Manufacturing.

hoffmann6383

07/08/22 11:54 AM

#493477 RE: exwannabe #493474

By the end of the year Advent is scheduled to attain commercial manufacturing certification. This will include the production for DCVax-L once it is approved by RAs. It is reasonable to assume RA approval for DCVax-L will be close to manufacturing certification even if a BLA/MAA has not yet been submitted as the approval process is often times shorter for an accelerated approval than it takes to grant commercial manufacturing certification.



I agree with this Ex! DCVax-L RA approval(s) are incoming! Have a good one my friend. by.

biosectinvestor

07/08/22 11:55 AM

#493478 RE: exwannabe #493474

Cell therapy companies even with phenomenal results often take much, much longer to file their application for marketing approval. Your information is it really very good.

manibiotech

07/08/22 11:57 AM

#493481 RE: exwannabe #493474

Well we don’t know if they have submitted BLA or not . They just haven’t PRed it maybe